QuikClot use in trauma for hemorrhage control: case series of 103 documented uses.

  title={QuikClot use in trauma for hemorrhage control: case series of 103 documented uses.},
  author={Peter M Rhee and Carlos V. R. Brown and Matthew J. Martin and Ali Salim and David S Plurad and Donald J. Green and Lowell W Chambers and Demetrios Demetriades and George Velmahos and H Alam},
  journal={The Journal of trauma},
  volume={64 4},
BACKGROUND Local hemostatics have recently been introduced for field use to control external hemorrhage. The objective of this report is to describe the initial clinical experience with QuikClot, a zeolite that works by absorbing water and concentrating coagulation factors to stop bleeding in a series of patients. METHODS Documented cases using a self-reporting survey sheet submitted by the users and first-hand detailed interviews with the users when possible. RESULTS There were 103… Expand
Hemostatic dressings in civil prehospital practice: 30 uses of QuikClot Combat Gauze
  • S. Travers, H. Lefort, +4 authors J. Tourtier
  • Medicine
  • European journal of emergency medicine : official journal of the European Society for Emergency Medicine
  • 2016
The provision of hemostatic dressings in civilian resuscitation ambulances was useful by providing an additional tool to limit bleeding while rapidly transporting the injured patient to a surgical facility. Expand
Successful use of intrapelvic Quikclot in life-threatening blast injury☆
Although not officially recommended, intracorporeal uses of Quikclot™ can be effective as a last resort in preventing loss of life in cases of severe polytrauma, however, users need to remain wary of complications which may arise due to its application. Expand
QuikClot Combat Gauze Use for Hemorrhage Control in Military Trauma: January 2009 Israel Defense Force Experience in the Gaza Strip—A Preliminary Report of 14 Cases
This report on the clinical field use of the QCG dressing by ALS providers suggests that it is an effective and safe product, and applicable for prehospital treatment of combat casualties, and suggests that QCG should be issued to medics as well as ALS providers. Expand
Thirty consecutive uses of a hemostatic bandage at a US Army combat support hospital and forward surgical team in Operation Iraqi Freedom.
  • D. King
  • Medicine
  • The Journal of trauma
  • 2011
The MRDH bandage was an effective hemostat for temporarily controlling hemorrhage in difficult circumstances and should be exercised when removing the dressing as rebleeding may occur. Expand
Prehospital use of hemostatic dressings in emergency medical services in the Netherlands: A prospective study of 66 cases.
This largest prospective study in civilian healthcare and the second largest case series with prehospital use of hemostatic dressings demonstrated that ChitoGauze is an effective and safe adjunct in the prehospital treatment of massive external traumatic haemorrhage. Expand
A multi-institutional study of hemostatic gauze and tourniquets in rural civilian trauma
QuikClot combat gauze and CAT are safe and effective adjuncts for hemorrhage control in the rural civilian trauma across a wide range of injury patterns and are associated with minimal morbidity beyond that of the original injury. Expand
Bleeding Control Using Hemostatic Dressings: Lessons Learned.
  • B. Bennett
  • Medicine
  • Wilderness & environmental medicine
  • 2017
There is adequate evidence of hemorrhage control effectiveness in both military and civilian preclinical studies and clinical case series and the Committee on Tactical Combat Casualty Care recommends implementing approved hemostatic dressings as one part of a comprehensive hemorrhages control training and clinical management program. Expand
Pre-hospital haemostatic dressings: a systematic review.
HemCon and QuikClot have augmented the haemostatic capabilities of the military first aid responder, but newer products demonstrate potential to be more effective and should be considered as replacements for current in service systems. Expand
[Prehospital use of haemostatic dressing QuikClot ACS+™ for hemorrhage control of a perineal trauma].
The case of a worker victim of an accident of construction site with hemorrhagic perineal trauma for whom the use of a haemostatic bandage QuikClot ACS+™ (Z-Medica) seemed to us particularly useful in prehospital setting is reported. Expand
A systematic review on the use of topical hemostats in trauma and emergency surgery
Local hemostatic agents are dissimilar products with different indications and a knowledge of the properties of each single agent should be in the armamentarium of acute care surgeons in order to select the appropriate product in different clinical conditions. Expand


Comparison of 10 different hemostatic dressings in an aortic injury.
With one 4-minute application, a single fibrin dressing stopped bleeding from an aortotomy, which was equivalent to sutured repair, and no other test group exhibited any evidence of significant hemostatic efficacy. Expand
Intracorporeal use of the hemostatic agent QuickClot in a coagulopathic patient with combined thoracoabdominal penetrating trauma.
This case represents the first reported intracorporeal use of a novel hemostatic agent, QuikClot (Z-Medica, Newington, CT), resulting in immediate lifesaving hemorrhage control in a patient with hemorrhage not amenable to conventional methods of hemostasis. Expand
Hemorrhage control in the battlefield: role of new hemostatic agents.
A number of hemostatic agents have recently been deployed to the warfront that can be used to arrest bleeding before surgical control of the source. Expand
Testing of modified zeolite hemostatic dressings in a large animal model of lethal groin injury.
The use of zeolite hemostat can control hemorrhage and dramatically reduce mortality from a lethal groin wound in a swine model of battlefield injury. Expand
Comparative analysis of hemostatic agents in a swine model of lethal groin injury.
Of the hemostatic agents tested, QuikClot improved survival and decreased bleeding in a swine model of lethal vascular and soft tissue injury. Expand
Application of a granular mineral-based hemostatic agent (QuikClot) to reduce blood loss after grade V liver injury in swine.
QuikClot provides hemostasis and decreased mortality in this model of severe liver injury and must, however, be balanced against the tissue-damaging effects of the exothermic reaction. Expand
Application of a zeolite hemostatic agent achieves 100% survival in a lethal model of complex groin injury in Swine.
The use of zeolite hemostatic agent (1% residual moisture, 3.5 oz) can control hemorrhage and dramatically reduce mortality from a lethal groin wound and increasing the RM adversely affected efficacy without any significant decrease in wound temperatures. Expand
Does the rate of rewarming from profound hypothermic arrest influence the outcome in a swine model of lethal hemorrhage?
Testing the impact of different warming rates on outcome in a swine model of lethal hemorrhage from complex vascular injuries found rapid induction of hypothermic arrest maintains viability of brain during repair of lethal vascular injuries. Expand
Advanced hemostatic dressing development program: animal model selection criteria and results of a study of nine hemostatic dressings in a model of severe large venous hemorrhage and hepatic injury in Swine.
The hemorrhage model allowed differentiation among topical hemostatic agents for severe hemorrhage and warrants further development and the American Red Cross he mostatic dressing was effective. Expand